GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems
FASEB BioAdvances · 2025-03 · 7 (3)
DOI: 10.1096/fba.2024-00180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FASEB BioAdvances, online erschienen am 31.01.2025. Verfasst von Tahmid Faisal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy University of Houston Houston Texas USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
G protein‐coupled receptors (GPCRs), which play crucial roles in various physiological functions, often assembled into dimers and higher‐order oligomers. This oligomerization phenomenon has been observed in diverse physiological and pathological contexts, presenting promising opportunities for drug discovery targeting vital systems such as the cardiovascular, nervous, endocrine, and renal systems. This review offers a concise understanding of GPCR dimerization, its signaling mechanisms, and its implications. Furthermore, we explored therapeutic strategies aimed at modulating receptors involved in dimer/oligomer formation within the renin‐angiotensin system.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy University of Houston Houston Texas USA.
ORCID-Profile: Tahmid Faisal, Tahir Hussain
Förderung
- NIDDK NIH HHS
Zitieren
APA
Faisal, T., & Hussain, T. (2025). GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems. FASEB BioAdvances, 7(3). https://doi.org/10.1096/fba.2024-00180
Vancouver
Faisal T, Hussain T. GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems. FASEB BioAdvances. 2025;7(3). doi:10.1096/fba.2024-00180
BibTeX
@article{Faisal2025,
author = {Faisal, Tahmid and Hussain, Tahir},
title = {GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems},
journal = {FASEB BioAdvances},
year = {2025},
volume = {7},
number = {3},
doi = {10.1096/fba.2024-00180}
}
EUVIMED